ANNALS OF HEMATOLOGY

Note: The following journal information is for reference only. Please check the journal website for updated information prior to submission.

Journal Title

ANN HEMATOL

ISSN / eISSN

0939-5555 / 1432-0584

Aims and Scope

Annals of Hematology covers the whole spectrum of clinical and experimental hematology, hemostaseology, blood transfusion, and related aspects of medical oncology, including diagnosis and treatment of leukemias, lymphatic neoplasias and solid tumors, and transplantation of hematopoietic stem cells. Coverage includes general aspects of oncology, molecular biology and immunology as pertinent to problems of human blood disease. The journal is associated with the German Society for Hematology and Medical Oncology, and the Austrian Society for Hematology and Oncology.

Subject Area

HEMATOLOGY

CiteScore

5.50

View Trend

CiteScore Ranking

Category	Quartile	Rank
Medicine - Hematology	Q2	#44/129

Web of Science Core Collection

Science Citation Index Expanded (SCIE)	Social Sciences Citation Index (SSCI)
Indexed	-

Category (Journal Citation Reports 2023)	Quartile
HEMATOLOGY - SCIE	Q2

H-index

Country/Area of Publication

GERMANY

Publisher

Springer Berlin Heidelberg

Publication Frequency

Monthly

Year Publication Started

1955

Annual Article Volume

217

Open Access

Contact

SPRINGER, 233 SPRING ST, NEW YORK, USA, NY, 10013

Popular journals in the same field
Recent articles

CEAC (oral semustine, etoposide, cytarabine and cyclophosphamide) vs BEAM (carmustine, etoposide, cytarabine, and melphalan) conditioning regimen of autologous stem cell transplantation for diffuse large B-cell lymphoma: a post-hoc, propensity score-matched, cohort study in Chinese patients: (2023) Tao Wang, Ping Liu, Lili Xu, Lei Gao, Xiong Ni, Gusheng Tang, Li Chen, Jie Chen, Libing Wang, Yang Wang, Weijia Fu, Wenqin Yue, Na Liu, Ruobing Li, Gu...

Distinct FDG PET/CT avidity among newly diagnosed intravascular large B-cell lymphoma patients: a descriptive observational study: (2023) Danqing Zhao, Yan Zhang, Wenjia Zhu, Li Huo, Daobin Zhou, Wei Wang, Chong Wei, Wei Zhang

Safe utilization of ruxolitinib in simultaneous primary myelofibrosis and warm autoimmune hemolytic anemia: (2023) Victor Pope, Cyrus C. Hsia

Hypomethylating agents (HMAs) show benefit in AML rather than in intermediate/high-risk MDS based on genetic mutations in epigenetic modification (EMMs): from a retrospective study: (2023) Ruiqi Wang, Yuanyuan Xu, Bianhong Wang, Hong Wang, Mengzhen Wang, Yu Jing, Xiaoning Gao, Li Yu

Non-viral pathogens of infectious diarrhoea post-allogeneic stem cell transplantation are associated with graft-versus-host disease: (2023) Matthew J. Rees, Alexandra Rivalland, Sarah Tan, Mingdi Xie, Michelle K. Yong, David Ritchie

Pulmonary Erdheim-Chester disease successfully treated with vemurafenib: (2023) Kai-ni Shen, Long Chang, Na Niu, Jian Li, Xin-xin Cao

Feasibility of allogeneic hematopoietic stem cell transplantation in advanced age: (2023) Sara Fernandez-Luis, David Gomez Lamas, Juan Manuel Cerezo Martin, Juan Manuel Mora Barrios, Lucrecia Yañez San Segundo, Miriam Sanchez Escamilla, Noe...

The clinical spectrum and prognostic factors of Erdheim-Chester disease and mixed Langerhans cell histiocytosis and Erdheim-Chester disease: (2023) Jia‑wen Dai, He Lin, Long Chang, Jian Li, Dao-bin Zhou, Xin-xin Cao

Epigenetically dysregulated NOTCH-Delta-HES signaling cascade can serve as a subtype classifier for acute lymphoblastic leukemia: (2023) Syeda Saliah Hussan, Muhammad Shrafat Ali, Mishal Fatima, Memoona Altaf, Saima Sadaf

Correction to: A case of sudden hearing loss in a patient with chronic myelomonocytic leukemia: (2023) Rodrick Babakhanlou, Marc-Elie Nader, Yesid Alvarado

Verified Reviews

Note: Verified reviews are sourced from across review platforms and social media globally.

May I ask in which month you received your first repair feedback? I have been under review for 6 months, and it is still under review. I'm in a hurry.

2022-03-02

The review process is long, starting from submission, major revision, minor revision, to acceptance, totaling 1 year and 6 days.

2022-01-21

View All Reviews

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More